The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada

被引：14

作者：

Alan, S

Crossley, TF

Grootendorst, P

Veall, MR

机构：

[1] McMaster Univ, Dept Econ, Hamilton, ON L8S 4M4, Canada

[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada

[3] St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON, Canada

[4] York Univ, Dept Econ, Toronto, ON M3J 2R7, Canada

[5] McMaster Univ, Res Program Social & Econ Dimens Aging Populat, Hamilton, Vic, Australia

[6] Australian Natl Univ, Res Sch Social Sci, Ctr Econ Policy Res, Canberra, ACT, Australia

[7] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada

[8] St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON, Canada

来源：

JOURNAL OF HEALTH ECONOMICS | 2002年 / 21卷 / 05期

基金：

加拿大健康研究院;

关键词：

prescription drug subsidies; incidence; redistribution; progressivity;

D O I：

10.1016/S0167-6296(02)00012-7

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

Between 1970 and 1986, all Canadian provinces introduced some version of a prescription drug subsidy for those aged 65 years or over and since 1986, all the provinces have increased copayments or deductibles to some degree. Employing a first-order approximation to the welfare gains from a subsidy, we find evidence that these subsidies have been less redistributive than an absolute per household cash transfer but slightly more redistributive than a transfer that would increase each household's income by the same percentage. Such evidence may have relevance for predicting the redistributive effects of a potential national prescription drug plan for seniors in the US. (C) 2002 Elsevier Science B.V. All rights reserved.

引用

页码：805 / 826

页数：22

共 26 条

[1] Tax reform and welfare measurement: Do we need demand system estimation? [J].